Press Release
 View printer-friendly version |
| FDA Approves Alcon's AcrySof(R) IQ ReSTOR(R) +3.0 D Intraocular Lens |
New Lens Corrects for Cataracts with Presbyopia HUENENBERG,
"The introduction of this lens allows me to deliver a full range of
quality vision for my patients' needs, lifestyles and personal
preferences. In my experience, the AcrySof(R) IQ ReSTOR(R)
+3.0 D add IOL gives my patients a more comfortable reading distance,
improved intermediate vision for tasks such as computer work and
excellent distance vision," said study investigator, The US clinical trials included a three-month follow-up exam of near, intermediate and distance visual acuities. The percentage of patients who achieved 20/20 or better at all three distances with the AcrySof(R) IQ ReSTOR(R) +3.0 D was nearly fourfold the rate of patients who received the control lens, AcrySof(R) IQ ReSTOR(R) +4.0 D. The clinical studies also showed a high rate of patient satisfaction with over 95 percent of patients stating that they would have this lens implanted again.
"Advanced technology IOLs that correct for presbyopia and astigmatism
are the fastest growing IOL segment of cataract surgery. The addition of
this new lens meets a growing desire on the part of cataract patients
for spectacle independence after cataract surgery. With the availability
of the AcrySof(R) IQ ReSTOR(R)+3.0 D lens, surgeons
can deliver true performance at all distances for their cataract
patients," said About AcrySof(R) Intraocular Lenses Alcon's AcrySof(R) intraocular lenses are the most frequently implanted lenses in the world, with more than 35 million implants since their introduction in the early 1990s. Alcon's AcrySof(R) IOLs offer cataract patients a variety of benefits that give cataract patients a full range of quality vision. The AcrySof(R) IQ, AcrySof(R) Toric and AcrySof(R) IQ ReSTOR(R) IOLs are part of Alcon's AcrySof(R) product portfolio. Since the introduction of the Acrysof(R) ReSTOR(R) platform, Alcon has accounted for more than half of all presbyopia correcting lenses implanted. For more information visit www.acrysofrestor.com. About Cataract Surgery A cataract is a "clouding" of the eye's natural lens, which results in blurred or defocused vision. IOLs are implanted during cataract surgery to replace the patient's natural lens that has been removed during surgery. Cataracts cannot be prevented and are the leading cause of treatable blindness worldwide. For more information visit www.cataractsurgery.com. About Alcon
Caution Concerning Forward-Looking Statements. This press
release may contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Any
forward-looking statements reflect the views of our management as of the
date of this press release with respect to future events and are based
on assumptions and subject to risks and uncertainties. Given these
uncertainties, you should not place undue reliance on these
forward-looking statements. Except to the extent required under the
federal securities laws and the rules and regulations promulgated by the
CONTACT: |